Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Qizhu anticancer prescription enhances immunosurveillance of liver cancer cells by regulating p21-dependent secretory phenotypes.

Journal of ethnopharmacology - 28 Oct 2024

Hu Rui, Li Jing, Huang Qi, Zhong Xin, Sun Jialing, Yi Jinyu, Peng Lanfen, Liu Xinning, Yang Yuan, Yang Wenmin, Wang Yan, Ma Wenfeng, Feng Wenxing, Xu Youhua, Zhou Xiaozhou

Abstract excerpt

ETHNOPHARMACOLOGICAL RELEVANCE: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide, largely due to the limitations of available therapeutic strategies. The traditional Chinese medicine Qizhu Anticancer Prescription (QZACP) can improve the quality of life and prolong the survival time of patients with HCC. However, the precise mechanisms underlying the anti-cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Proliferation

Share to Cyclin-Dependent Kinase Inhibitor p21

Share to Drugs, Chinese Herbal

Share to Immunologic Surveillance

Share to Liver Neoplasms

Share to Mice, Inbred C57BL

Source

Identifiers

PMID: 38823657
DOI: 10.1016/j.jep.2024.118400

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Qizhu anticancer prescription enhances immunosurveillance of liver cancer cells by regulating p21-dependent secretory phenotypes.PMID 38823657Read ↗

Exploring Senescence-Related Transcriptional Signatures to Uncover Molecular Subtypes and Key Genes in Hepatocellular CarcinomaSemantic proximity Read ↗

A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinomaSemantic proximity Read ↗

Integrative analysis of senescence-related genes identifies robust prognostic clusters with distinct features in hepatocellular carcinomaSemantic proximity Read ↗

Identification of CCNB1 as a biomarker for cellular senescence in hepatocellular carcinoma: a bioinformatics and experimental validation studySemantic proximity Read ↗

Paradoxical effects of cellular senescence-inhibited gene involved in hepatocellular carcinoma migration and proliferation by ERK pathway and mesenchymal-like markersSemantic proximity Read ↗

Pyrimethamine inhibits cell growth by inducing cell senescence and boosting CD8+ T-cell mediated cytotoxicity in colorectal cancerSemantic proximity Read ↗

Attenuation of pro-tumorigenic senescent secretory phenotype by StN, a novel derivative of stevioside, potentiates its inhibitory activity on hepatocellular carcinoma.Semantic proximity Read ↗

Comprehensive Analysis of Cellular Senescence-Related Genes in Prognosis, Molecular Characterization and Immunotherapy of Hepatocellular CarcinomaSemantic proximity Read ↗

GPX4 predicts poor prognosis and regulates tumor proliferation and senescence in colorectal adenocarcinomaSemantic proximity Read ↗

New concept: cellular senescence in pathophysiology of cholangiocarcinoma.Semantic proximity Read ↗

Network pharmacological analysis of corosolic acid inhibits hepatocellular carcinoma progression through P4HA2Semantic proximity Read ↗

Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and Attenuates Development of Hepatocellular Carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.